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Background: The aim of our study was to determine the impact of vascular access on
in-hospital major bleeding (IHMB), particularly in acute coronary syndrome (ACS)
patients with moderate- to very high-bleeding risk.
Methods: We analyzed 995 ACS patients with the Can Rapid risk stratification of
Unstable angina patients Suppress ADverse outcomes with Early implementation of the
ACC/AHA guidelines (CRUSADE) moderate- to very high-bleeding risk scores in
trans-radial intervention (TRI) retrospective registry from 16 centers in Korea. 402
patients received TRI (TRI group) and 593 patients trans-femoral intervention (TFI
group). The Primary end-point was IHMB as defined in the CRUSADE.
Results: The use of 600mg loading dose of clopidogrel and low molecular weight heparin
were more common in TRI, however, the use of unfractionated heparin and glycoprotein
IIb/IIIa inhibitors were more common and hematocrit, creatinine clearance, blood
pressure and heart rate at admission were lower in TFI. TRI had lower incidences of
IHMB and blood transfusion than TFI (6.0% vs. 9.4%, p0.048; 4.5% vs. 9.4%,
p0.003). The patients suffered from IHMB had higher incidences of in-hospital and
1-year mortality than those free from IHMB (3.1% vs. 15.0%, p0.001; 7.2% vs. 30.0%,
p0.001). TRI was an independent predictor of IHMB (odds ratio: 0.305; 95%
confidence interval: 0.109-0.851; p0.003).
Conclusions: IHMB is still significantly correlated with in-hospital and 1-year mortality.
Our study suggests that compared to TFI, TRI could reduce IHMB in ACS with the
moderate- to very high-bleeding risk.
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Background: Contrast-induced nephropathy (CIN) is the major cause of hospital-
acquired renal failure. Although the efficacy of sodium bicarbonate to prevent CIN was
reported, long-term cardiovascular and renal outcome is unclear.
Methods: Between May 2006 and March 2010, 161 patients of multicenter with CKD
(Scr 1.2 mg/dl) who underwent cardiac catheterization were prospectively randomized
to receive short infusion of sodium bicarbonate (n80, 3ml/kg/h for 1h before, then
1ml/kg/h for 6h after procedure) or long infusion of 0.9% saline (n81, 1ml/kg/h for 12 h
before and for 12 h after procedure). Primary endpoint is the incidence of CIN defined
increase Scr more than 0.5mg/dl or 25% within 48 hours after procedure. Secondary
endpoint was cardiovascular and renal outcome 1 year after procedure.
Results: Two groups were well matched for baseline characteristics without age,
hypertension. The incidence of CIN was not different between 2 group (bicarbonate 8.8%
vs saline 2.5%, p0.10), One-year follow-up was completed with 124 patients (95%).
The change of %Cr and estimated GFR were not different in two groups (Cr 0.200.62
mg/dl vs 0.250.63 mg/dl, p0.67 : eGFR -2.78.8 vs -4.88.1 p0.12). No significant
difference was observed in two groups about the composite cardiovascular event and the
composite renal event.
Conclusions: Short infusion of sodium bicarbonate has almost similar effects on
incidence of CIN and long-term cardiovascular and renal outcome compared with the
standard saline infusion.
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Background: HAS-BLED score predicts bleeding risk in patients with atrial fibrilla-
tion.We have simplified the risk score and assessed its validity in a contemporary cohort
of patients who underwent percutaneous coronary intervention (PCI).
Methods: The study included 1851 consecutive patients undergoing PCI between
January 2010 and March 2012.We simplified the HAS-BLED score to BLEEDRS score
using routinely collected variables(Bleeding history,Low hemoglobin,Elderly,Elevated
BP, Drugs, Renal disease,Stroke).We assessed major bleeding events as per NCDR
definition.
Results: The median patient age was 65 years and 66% were male.Transfemoral access
was used in 83% and primary PCI was performed in 24.4% of the patients.Peri-procedural
antiplatelet and anticoagulation therapy included:aspirin(97%), clopidogrel(57%), prasu-
grel(37%), bivaluridin(32%), enoxaparin(9%), GPIIb/IIIa inhibitor(21%) and hepa-
rin(52%). The median BLEEDRS score was 2(0-6). We divided the patients into tertiles:
BLEEDRS (1)score2; BLEEDRS (2)score2 and5; BLEEDRS (3)score5. 5.1%
of the entire cohort of patients developed in-hospital bleeding events, 1.7% in BLEEDRS
(1),9.6% in BLEEDRS (2), and 20% in BLEEDRS (3)(P0.001). The BLEEDRS levels
were an independent determinant of bleeding after adjusting for gender, antiplatelet and
anticoagulation agents (P0.05). The calibration of the BLEEDRS score was good
(Hosmer-Lemeshow, P0.5), and its discriminatory capacity was acceptable, with an area
under the ROC curve of 0.75 (95% CI:0.71–0.79) (Figure-1)
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Conclusions: BLEEDRS – an adapted simplification of HASBLED score predicts major
bleeding events after PCI.
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Background: Oxidation of lipoproteins generates multiple bioactive oxidized lipids that
affect atherothrombosis and endothelial dysfunction, but direct evidence of their role
during therapeutic procedures is lacking. Liberated oxidized lipids may result in no-reflow
phenomenon, myocardial infarction and stroke. To assess whether oxidized vasoactive
lipids are released downstream from atherosclerotic plaques following percutaneous
coronary and peripheral interventions we undertook a lipidomic analysis of material
recovered from distal embolic protection devices from different vascular beds.
Methods: The presence of specific oxidized lipids was assessed in embolized material
captured by distal embolic protection devices during saphenous vein graft, carotid, renal,
and superficial femoral artery interventions. Following lipid extraction, specific oxidized
phospholipids (OxPL) and cholesterol esters (OxCE) were quantified in 12 filters using
liquid chromatography, tandem mass spectrometry.
Results: Phosphatidylcholine (PC) containing OxPL, including 1-palmitoyl-2-(5-
oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC), C9 aldehyde PC, E2 and F2 iso-
prostane PC, and hydroperoxy PC were identified in the extracted lipid portion. The major
oxidized PC by mass was the C9 aldehyde PC, representing 38% of all oxidized PL.
Several species of OxCE, such as aldehyde, hydroperoxide, oxide and epoxy cholesterol
ester derivatives from cholesteryl linoleate and cholesteryl arachidonate, were also
present. The pattern of OxPL and OxCE within filters correlated well with molecules
found in various forms of oxidized LDL and did not differ significantly in different
vascular beds. The presence of OxPL was also confirmed using ELISA and immunohis-
tochemistry.
Conclusions: This is the first documentation of the presence and direct release of
oxidized lipids from atherosclerotic plaques during percutaneous interventions from
multiple vascular beds in humans. The release of such oxidized lipids into the microcir-
culation may mediate some of the adverse clinical outcomes that result during these
intravascular interventions.
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Background: An intra-coronary device becoming stuck is a very uncommon compli-
cation that may lead to tragic consequences such as occlusion of the artery and systemic
embolism.
Methods: Of 14,198 lesions in 13,188 patients who underwent PCI between 1999 and
2011, 40 device stuck (0.28%) incidents occurred during PCI procedures. The incidence,
outcomes and management of these device stuck occurrences were evaluated.
Results: The overall procedural success rate was 97.8% (13,884/14,198). The stuck
devices included stents (n20; 50%), wires (n14; 35%), balloons (n4; 10%),
intra-vascular ultrasound (n1; 2.5%), and rotablator burrs (n1; 2.5%), respectively.
Management of the complication and acute/long-term outcomes are shown in the table. Of
54 instances of device stuck, 15 (37.5%) were retrieved successfully, and 7 (18%)
resulted in rupture and were left in the coronary artery. Thirty-seven patients recovered in
the cath-lab and the rest (N3) were referred to emergency CABG. At 1-year follow-up,
all patients were alive, although the segment of the coronary artery where the device
stuck occurred was occluded in 2 cases on agiographic findings.
Conclusions: Although the rate of this complication during PCI was very low, all cases
were solved with optimal treatment and all patients survived at 1-year follow-up. A safe
procedure with careful device manipulation should be required for PCI, with appropriate
management leading to better outcomes.
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Background: Recent advances in antithrombotic therapy for STEMI are accompanied
by an increased risk of bleeding. So far, the CRUSADE score for bleeding risk has only
been validated in NSTEMI.
Methods: The risk of in-hospital major CRUSADE bleeding and 1-year mortality after
primary PCI for STEMI was studied in consecutive patients who received upfront
abciximab, periprocedural heparin and loading doses of aspirin and clopidogrel.
Results: In total, 965 STEMI patients (6112 yrs, 76% men) were stratified according
to the CRUSADE bleeding risk score (Table). Median CRUSADE score was 21 (14-29).
Bleeding was common (21%) ranging from 11% in the very low risk group up to 69% in
the very high risk group. Most common bleeding site was the femoral access site. In 3
patients, bleeding most likely led to death. Survival analysis demonstrated 1-year
mortality rates of 9.2% in bleeders vs. 2.5% in non-bleeders (p0.001, Figure).
Assessment of the CRUSADE risk score by ROC curve resulted in an area under the
curve of only 0.68 (0.64-0.73, p0.001).
CRUSADE bleeding risk score Non-bleeders Bleeders
Very low risk 399 (88.9%) 50 (11.1%)
Low risk 230 (75.9%) 73 (24.1%)
Moderate risk 95 (69.3%) 42 (30.7%)
High risk 39 (65.0%) 21 (35.0%)
Very high risk 5 (31.3%) 11 (68.8%)
In-hospital major bleeding in CRUSADE bleeding risk score categories
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